CSL reported $5.07 in EPS Earnings Per Share for its fiscal semester ending in December of 2025.





Eps Change Date
Alterity Therapeutics Limited AUD 0 0 Dec/2025
Arca Biopharma USD -0.58 0.04 Mar/2026
aTyr Pharma USD -0.06 0.59 Mar/2026
Bio Path USD -0.04 0.04 Mar/2026
Brainstorm Cell Therapeutics USD -0.19 0 Mar/2026
Cara Therapeutics USD -0.72 0.14 Mar/2026
CSL USD 5.07 3 Dec/2025
Curis USD -11.82 13.04 Mar/2026
Immunic USD -0.1 0.03 Dec/2025
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
TherapeuticsMD USD -0.09 0.02 Jun/2024